Participants 0 135 4
Pharmacodynamic analysis of intravenous recombinant urate oxidase using an indirect pharmacological response model in healthy subjects.
Participants 157 206 4
analysis of intravenous recombinant urate oxidase
Participants 250 323 4
in healthy subjects using a pharmacokinetic/pharmacodynamic (PK/PD) model
Participants 403 480 7
40 healthy Chinese subjects (4 groups of 10 subjects each, placebo 4:1 ratio)
Participants 1492 1573 3
N The PK/PD model predicted the effective dose to be 0.1 mg/kg in healthy subject
